XNAS · KPTI
+1.10% · +$0.0200 · Vol 162.5K
Live · updated 10:21:16 ET
Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc.

PHARMACEUTICAL PREPARATIONS
$1.83
Card
Relationship Map

Veridion Score

BETALOW CONF · 6/6 factorsMethodology
KPTI
Karyopharm Therapeutics Inc.
Mon Aug 17 · last completed session · daily score · 16h old
SELL BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

44/ 100
Veridion Score
SELL BIAS · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 6/6 factors with data · Mon Aug 17 · last completed session · daily score · 16h old
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is KPTI moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading KPTI catalysts
About Karyopharm Therapeutics Inc.
PHARMACEUTICAL PREPARATIONS
Listed since
2013
Employees
228
Country
US

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$1.88
Day high
$1.89
Day low
$1.82
Previous close
$1.81
52W high
$10.67
-82.85% from high
52W low
$1.81
0% of range
Market cap
$45.8M
EPS
$-11.7000
Beta
-0.73
Shares out
22.7M
Volume
162.5K
0.08× rel vol
Avg volume
2M
VWAP
$1.86
Price history computed in-house
1W
-12.86%
1M
-80.76%
3M
-77.07%
1Y
-67.26%
YTD
-75.14%
SMA 50 $7.31 · below
SMA 200 $7.40 · below
52W position 0%

KPTI overview

Veridion Score
44
Daily close · 2026-08-17
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around KPTI.Congress disclosuresOpen receipt and filing context for KPTI.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading KPTI Form 4 filings
Public disclosures

Congress activity in KPTI

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for KPTI in the cached public ledger.

Federal contracts

KPTI contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for KPTI in this window.
Lobbying spend

KPTI lobbying filings, year to date.

Registered lobbying filings matched to Karyopharm Therapeutics Inc..

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for KPTI in this window.
Loading news for KPTI
Analyst ratings
Sovereign unlock shows live analyst consensus for KPTI.
Options
Sovereign unlock shows live options positioning for KPTI.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.